By Irene Yeh As incretin-based medications, including glucagon-like peptide-1 receptor agonists (GLP-1RAs) or glucose-dependent insulinotropic polypeptide (GIP) drugs, become increasingly common in obesity and weight management, questions remain about their...
Read MoreBy Deborah Borfitz Medical conditions vary widely in presentation, progression, and treatment response, with Down syndrome standing out as one of the most variable of all. The genetic occurrence, caused...
Read MoreBy Irene Yeh Eating a healthy diet during pregnancy may come with an unexpected tradeoff: some foods recommended for good nutrition can also be sources of environmental chemical exposure. The...
Read MoreBy Irene Yeh Originally developed to treat type 2 diabetes and later for obesity management, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are rapidly expanding into other areas of treatment. Researchers...
Read MoreBy Deborah Borfitz The findings of more than 150 randomized controlled trials provide ample evidence that early mobilization of patients with acute respiratory failure (ARF) in the intensive care unit...
Read MoreBy Integrative Health Staff Earlier this month, KAIST announced the official launch of the KAIST Mind Care & Growth Center (KMCG), a novel integrated platform that enhances mental health support...
Read MoreBy Deborah Borfitz The diagnosis and management of hypertension is in a troublingly bleak state, despite myriad treatments and regular blood pressure checks in primary care settings intended to catch the condition early. The...
Read MoreBy Irene Yeh Food intervention programs not only benefit patients by improving their lifestyle and health conditions but can enhance local economies, quality performance, and chronic care outcomes. At this...
Read More